Subscribe to RSS
Download PDF
DOI: 10.1055/s-0044-1791678
Pattern and Predictors of Neurologic Comorbidities Among African Children with Epilepsy
Funding None.
Abstract
Background Epilepsy is the most common neurologic disorder affecting children in Nigeria. It is often associated with other neurologic comorbidities in addition to epileptic seizures, such as attention deficit hyperactivity disorder (ADHD) and cognitive, visual, and hearing impairments, which can be unrecognized while focusing on the seizures.
Methods This cross-sectional study assessed the prevalence, pattern, and predictors of neurologic comorbidities among 100 children with epilepsy (CWE) attending the pediatric neurology clinic of Jos University Teaching Hospital, Jos, Nigeria, and age- and sex-matched controls selected consecutively. Data were summarized using frequencies and proportions. Chi-squared and Mann–Whitney U tests were used to test the categorical values, while logistic regression was used to determine the predictive factors for neurologic comorbidities.
Results The prevalence of neurologic comorbidities among CWE versus controls was 65 vs. 15% (p < 0.001). Factors associated with neurologic comorbidities in CWE include younger age at onset of epileptic seizures (p < 0.003), severity of seizures (p < 0.001), history of status epilepticus (p < 0.044), background history of intracranial infections (p < 0.029), and the use of combination antiepileptic drugs (p < 0.001). Predictors of comorbidities in CWE were treatment with sodium valproate and polytherapy.
Conclusion Neurologic comorbidities are more frequent among CWE than controls; therefore, screening for neurologic comorbidities should be routine when assessing and managing CWE.
Publication History
Received: 20 March 2024
Accepted: 09 September 2024
Article published online:
16 October 2024
© 2024. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Agrawal N, Govender S. Epilepsy and neuropsychiatric comorbidities. BJPsych Adv 2011; 17 (01) 44-53
- 2 Singh A, Trevick S. The epidemiology of global epilepsy. Neurol Clin 2016; 34 (04) 837-847
- 3 Lagunju IA, Okafor OO. An analysis of disorders seen at the paediatric neurology clinic, University College Hospital, Ibadan, Nigeria. West Afr J Med 2009; 28 (01) 38-42
- 4 de Boer HM, Mula M, Sander JW. The global burden and stigma of epilepsy. Epilepsy Behav 2008; 12 (04) 540-546
- 5 Adewuya AO, Oseni SB, Okeniyi JA. School performance of Nigerian adolescents with epilepsy. Epilepsia 2006; 47 (02) 415-420
- 6 Lagunju IA, Fatunde OJ, Takon I. Profile of childhood epilepsy in Nigeria. J Pediatr Neurol 2009; 7 (02) 135-140
- 7 Ogunlesi T, Ogundeyi M, Olowu A. Pattern of childhood epilepsies in Sagumu, Nigeria. Indian J Pediatr 2009; 76 (04) 385-389
- 8 Shatima DR, Ulonnam CC. The pattern of childhood epilepsies at National Hospital Abuja Nigeria. J Med Sci Clin Res 2014; 2 (06) 1367-1377
- 9 Baker GA. Assessment of quality of life in people with epilepsy: some practical implications. Epilepsia 2001; 42 (Suppl. 03) 66-69
- 10 Vaurio L, Karantzoulis S, Barr WB. The impact of epilepsy on quality of life. In: Chiaravalloti N, Goverover Y. eds. Changes in the Brain. New York, NY: Springer; 2017: 167-187
- 11 Hermann B, Seidenberg M, Jones J. The neurobehavioural comorbidities of epilepsy: can a natural history be developed?. Lancet Neurol 2008; 7 (02) 151-160
- 12 Tochukwu Echendu S, Joe-Ikechebelu N, Odita AO. et al. Perspective chapter: determinants of health-care seeking behaviors and quality of life in children with epilepsy in Nigeria. In: Marco Carotenuto, ed. Epilepsy during the Lifespan: Beyond the Diagnosis and New Perspectives. London: IntechOpen; 2024: 112-148
- 13 Baker GA, Camfield C, Camfield P. et al. Commission on outcome measurement in epilepsy, 1994–1997: final report. Epilepsia 1998; 39 (02) 213-231
- 14 Keezer MR, Sisodiya SM, Sander JW. Comorbidities of epilepsy: current concepts and future perspectives. Lancet Neurol 2016; 15 (01) 106-115
- 15 Shamsaei F, Cheraghi F, Zamani G. Comparing mental health of school-age children with and without epilepsy. Iran J Child Neurol 2016; 10 (03) 35-41
- 16 Brooks-Kayal AR, Bath KG, Berg AT. et al. Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy. Epilepsia 2013; 54: 44-60
- 17 Aaberg KM, Bakken IJ, Lossius MI. et al. Comorbidity and childhood epilepsy: a nationwide registry study. Pediatrics 2016; 138 (03) e20160921
- 18 Witt JA, Helmstaedter C. Should cognition be screened in new-onset epilepsies? A study in 247 untreated patients. J Neurol 2012; 259 (08) 1727-1731
- 19 Russ SA, Larson K, Halfon N. A national profile of childhood epilepsy and seizure disorder. Pediatrics 2012; 129 (02) 256-264
- 20 Fisher RS, Acevedo C, Arzimanoglou A. et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia 2014; 55 (04) 475-482
- 21 Sykes RM. Epilepsy in children in Benin City, Nigeria. Ann Trop Paediatr 2002; 22 (03) 287-296
- 22 Larsson K, Eeg-Olofsson O. A population based study of epilepsy in children from a Swedish county. Eur J Paediatr Neurol 2006; 10 (03) 107-113
- 23 Burton K, Rogathe J, Whittaker RG. et al. Co-morbidity of epilepsy in Tanzanian children: a community-based case-control study. Seizure 2012; 21 (03) 169-174
- 24 Doherty AJ, Harrison J, Christian DL. et al. The prevalence of comorbidities in epilepsy: a systematic review. Br J Neurosci Nurs 2022; 18 (02) 98-106
- 25 Chiappedi M, Beghi E, Ferrari-Ginevra O. et al. Response to rehabilitation of children and adolescents with epilepsy. Epilepsy Behav 2011; 20 (01) 79-82
- 26 Srinivas HV, Shah U. Comorbidities of epilepsy. Neurol India 2017; 65 (Suppl): S18-S24
- 27 Camfield CS, Camfield PR. Long-term social outcomes for children with epilepsy. Epilepsia 2007; 48 (Suppl. 09) 3-5
- 28 Reilly C, Atkinson P, Das KB. et al. Neurobehavioral comorbidities in children with active epilepsy: a population-based study. Pediatrics 2014; 133 (06) e1586-e1593
- 29 Gilmour H, Ramage-Morin P, Wong SL. Epilepsy in Canada: prevalence and impact. Health Rep 2016; 27 (09) 24-30
- 30 Linehan C, Tellez-Zenteno JF, Burneo JG, Berg AT. Future directions for epidemiology in epilepsy. Epilepsy Behav 2011; 22 (01) 112-117
- 31 Kanner AM. Psychiatric comorbidities in new onset epilepsy: should they be always investigated?. Seizure 2017; 49: 79-82
- 32 Datta SS, Premkumar TS, Chandy S. et al. Behaviour problems in children and adolescents with seizure disorder: associations and risk factors. Seizure 2005; 14 (03) 190-197
- 33 Ochoa-Gómez L, López-Pisón J, Lapresta Moros C. et al. A study of epilepsy according to the age at onset and monitored for 3 years in a regional reference paediatric neurology unit. An Pediatr (Barc) 2017; 86 (01) 11-19
- 34 Holmes GL. Effect of seizures on the developing brain and cognition. Semin Pediatr Neurol 2016; 23 (02) 120-126
- 35 Berg AT, Zelko FA, Levy SR, Testa FM. Age at onset of epilepsy, pharmacoresistance, and cognitive outcomes: a prospective cohort study. Neurology 2012; 79 (13) 1384-1391
- 36 Vining EP, Mellitis ED, Dorsen MM. et al. Psychologic and behavioral effects of antiepileptic drugs in children: a double-blind comparison between phenobarbital and valproic acid. Pediatrics 1987; 80 (02) 165-174
- 37 Domizio S, Verrotti A, Ramenghi LA, Sabatino G, Morgese G. Anti-epileptic therapy and behaviour disturbances in children. Childs Nerv Syst 1993; 9 (05) 272-274
- 38 Herranz JL, Armijo JA, Arteaga R. Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine, and valproate during monotherapy in children. Epilepsia 1988; 29 (06) 794-804
- 39 Forsythe I, Butler R, Berg I, McGuire R. Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate. Dev Med Child Neurol 1991; 33 (06) 524-534
- 40 Lin W, Lai KY. Sodium valproate: culprit or saviour of attention deficit hyperactivity disorder?. East Asian Arch Psychiatry 1999; 9 (01) 29
- 41 Daugaard CA, Pedersen L, Sun Y, Dreier JW, Christensen J. Association of prenatal exposure to valproate and other antiepileptic drugs with intellectual disability and delayed childhood milestones. JAMA Netw Open 2020; 3 (11) e2025570
- 42 Joshi R, Tripathi M, Gupta P, Gulati S, Gupta YK. Adverse effects & drug load of antiepileptic drugs in patients with epilepsy: monotherapy versus polytherapy. Indian J Med Res 2017; 145 (03) 317-326